objective human papillomavirus hpv infections remain a leading cause of mortality worldwidein the us strategies via screening and vaccination prevent hpvassociated cervical neoplasms but consume immense healthcare coststhe spice component curcumin has potent anticancer and antiviral properties which have been difficult to harness as a treatment due to its poor systemic bioavailabilitythis project tests the possibility of developing a curcuminbased therapy for cervical cancermethods using four hpv cervical cancer cell lines and normal fibroblasts we first tested the selectivity and potency of curcumin in eliminating hpv cellssubsequently we developed a curcuminbased cervical cream and tested its efficacy in eliminating apposed hpv cells and also its possible side effects on the vaginal epithelium of healthy miceresults curcumin selectively eliminates a variety of hpv cervical cancer cells hela me180 siha and sw756 suppresses the transforming antigen e6 dramatically inhibits the expression of the procancer protein epidermal growth factor receptor egfr and concomitantly induces p53additionally vacurin a uniform colloidal solution of curcumin in a clinically used amphipathic vaginal cream eliminates apposed hela cells while suppressing the expression of egfrin mice daily intravaginal application of vacurin for three weeks produced no change in body weight and when the mice were sacrificed the vaginal tract epithelium showed no vacurinevoked adverse effectsconclusion we have developed a curcuminbased vaginal cream which effectively eradicates hpv cancer cells and does not affect noncancerous tissueour preclinical data support a novel approach for the treatment of cervical hpv infectioncopyright  2012 elsevier inc all rights reserved